Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis - Wikidata - wikimedia - TriplyDB

Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis

Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis

http://www.wikidata.org/entity/Q34528402

about

Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients.Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.Diallyl trisulfide exerts cardioprotection against myocardial ischemia-reperfusion injury in diabetic state, role of AMPK-mediated AKT/GSK-3β/HIF-1α activation.

P2860

Q36144000-9C095914-9B2F-46BF-9FC2-93901FE6C70C Q36998088-A057144F-0498-472B-AC8A-658294B0907D Q37018236-917C2EFA-EA69-46F6-9293-259EF0D0DAA7 Q37209499-0BD4B49A-ACCB-49D3-97D7-AFAED721A96D Q38338199-78C9F346-D68B-4715-AF12-BFB880626203 Q46452587-BE524DA7-31BE-4540-9CEE-FF926AB57826

P2860

Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis

http://www.wikidata.org/entity/Q34528402

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@ast

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@en

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@nl

type

label

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@ast

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@en

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@nl

prefLabel

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@ast

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@en

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@nl

P1433

Q34528402-CFED89F5-1A96-40BC-B27C-2BF77B599376

P1476

Q34528402-F5800DA6-2E06-4C9D-AFF9-E64B453C05E1

P2093

Q34528402-80DA1E9B-26FB-41FA-8001-4252185B68D1

Q34528402-FD90ADDB-7E75-4DEF-9E97-765F99AB7394

P2860

Q34528402-0CD3AFD8-0BFF-4DE1-89F9-B4D1D183697F

Q34528402-11D15AB9-401A-48EF-A056-FE7B4A985EA9

Q34528402-15DF14F1-E0D3-4E9A-B1AE-16CCDFFADBFC

Q34528402-3B70D8D3-F0A2-4E7A-AE86-537B9D14B6B7

Q34528402-3B88E4BB-094E-4E87-A0F3-BC5A8F111A77

Q34528402-3C92D620-33EE-4550-81C2-BB03F54B8B15

Q34528402-40AC010D-76A5-44FD-BCA4-74C9D7287A02

Q34528402-4B2EA835-06B9-4EA8-AEEA-3F87DC7BDA6E

Q34528402-5BEA4382-7CAE-4DD1-9467-A04C25A66112

Q34528402-5FFFC205-8793-4DC1-A505-A949929A35BE

P2888

Q34528402-41018980-8BC1-4D12-8FA1-6C417142AF49

P304

Q34528402-C6A4C660-21B7-40C2-B612-723378FF4FD6

P31

Q34528402-0152C0CB-1F24-42A0-B256-379EDBE6F25A

P356

Q34528402-49E652F8-4626-492B-9202-06146B9FE53D

Q34528402-8B7A305A-7650-4909-9DE6-FD994C15B534

P407

Q34528402-76B723C2-3EEA-424E-94CE-05795D8D5121

P478

Q34528402-A3C3A3FD-9C56-4FC1-BADB-D14395B5FA0B

P577

Q34528402-46708DB5-974B-4D5E-B56A-73BB71C13D81

P6179

Q34528402-5ABFC3C4-C53A-41A2-B8CA-EB0F0419ECF9

P698

Q34528402-68EBDA2E-80D9-4F76-9DA1-4F02E68D88B6

P921

Q34528402-0C92DB1A-67EB-4E1F-8540-FBE7D22C4700

Q34528402-FD1B4164-12D3-4CA1-BAF7-29177CF87F8F

P932

Q34528402-7F8641D0-9DA6-4B1A-81EF-D3233AA75A57

P356

S12933-014-0152-5

P1433

Cardiovascular Diabetology

P1476

Activation of AMP-activated pr ...... against diabetic lipoapoptosis

@en

P2093

Linnéa Eriksson

http://www.w3.org/2001/XMLSchema#string

Thomas Nyström

http://www.w3.org/2001/XMLSchema#string

P2860

The roles of ASK family proteins in stress responses and diseases

Alteration of energy substrates and ROS production in diabetic cardiomyopathy

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

p38 mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-kappaB degradation in human coronary artery endothelial cells.

Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2

Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).

Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression.

P2888

s12933-014-0152-5

P304

152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-014-0152-5

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021307833

http://www.w3.org/2001/XMLSchema#string

P698

25391818

http://www.w3.org/2001/XMLSchema#string

P921

P932

4234893

http://www.w3.org/2001/XMLSchema#string